Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Champ Resto Indonesia Tbk. (ENAK) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Champ Resto Indonesia Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Champ Resto Indonesia Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Champ Resto Indonesia Tbk. trades at Rp268 (market cap 598B, 528.6K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: Champ Resto Indonesia Tbk. is far larger — about 3.6× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Champ Resto Indonesia Tbk. is more actively traded (528.6K versus 71K). Which is the better fit depends on your goals.

ENAKOBAT
Market Cap
598B167.37B
Volume
528.6K71K
Lot
5.29K710
Turnover
140.81M17.51M
Average Price
266.39246.63
Value
140.81M17.51M
Indicative Equilibrium Price
276246
Indicative Equilibrium Volume
1.7K1

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ENAK
View details
OBAT
View details

About Champ Resto Indonesia Tbk.

PT Champ Resto Indonesia Tbk ("Company") was established based on the Notarial Deed of Catherina Situmorang, S.H., No. 20 dated March 22, 2010.

Read more on ENAK

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT